For example, cardiac glycosides have been used as HIF-1α inhibitors, reducing proliferation and inducing autophagy and/or apoptosis in cancer cells [59]; or LBH589, a panobinostat that also reduces HIF-1α and VEGF levels [60]. The gene discussed is HIF1A; the disease is cancer.